Netabolics is a biotech company developing a platform for combinational drug repurposing in precision oncology.
Our patented technology integrates multi-Omics data, ordinary differential equations (ODE)-based genome-scale simulation, and deep reinforcement learning (DRL)-based drug target deconvolution to develop combination therapies sensitive to cancer diversity.